Truncating mutations were also validated in SCUBE2, RELN, FBXW7, MLL3, WTX/FAM123B, OTUD7B and KPRP across the MAP and FAP adenomas (see supplementary material, Table S3). The gene discussed is KPRP; the disease is adenoma.